Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
Abstract The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of
rapamycin (mTOR) represent two vital intracellular signaling pathways, which are …
rapamycin (mTOR) represent two vital intracellular signaling pathways, which are …
The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells
I Nepstad, KJ Hatfield, IS Grønningsæter… - International journal of …, 2020 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous group of diseases characterized by
uncontrolled proliferation of hematopoietic stem cells in the bone marrow. Malignant cell …
uncontrolled proliferation of hematopoietic stem cells in the bone marrow. Malignant cell …
Drug repurposing from the perspective of pharmaceutical companies
Drug repurposing holds the potential to bring medications with known safety profiles to new
patient populations. Numerous examples exist for the identification of new indications for …
patient populations. Numerous examples exist for the identification of new indications for …
miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells
To investigate miRNA function in human acute myeloid leukemia (AML) stem cells (LSC), we
generated a prognostic LSC-associated miRNA signature derived from functionally …
generated a prognostic LSC-associated miRNA signature derived from functionally …
Targeting PI3K/Akt/mTOR in AML: rationale and clinical evidence
S Darici, H Alkhaldi, G Horne, HG Jørgensen… - Journal of Clinical …, 2020 - mdpi.com
Acute myeloid leukemia (AML) is a highly heterogeneous hematopoietic malignancy
characterized by excessive proliferation and accumulation of immature myeloid blasts in the …
characterized by excessive proliferation and accumulation of immature myeloid blasts in the …
The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer
A Arif, AA Alameri, UB Tariq, SA Ansari, HI Sakr… - International …, 2023 - Elsevier
Currently, cancer ranks as the second leading cause of death worldwide, and at the same
time, the burden of cancer continues to increase. The underlying molecular pathways …
time, the burden of cancer continues to increase. The underlying molecular pathways …
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
SK Tasian, DT Teachey, Y Li, F Shen… - Blood, The Journal …, 2017 - ashpublications.org
Philadelphia chromosome (Ph)–like B-cell acute lymphoblastic leukemia (Ph-like ALL) is
associated with activated JAK/STAT, Abelson kinase (ABL), and/or phosphatidylinositol 3 …
associated with activated JAK/STAT, Abelson kinase (ABL), and/or phosphatidylinositol 3 …
Epigallocatechin gallate and mitochondria—a story of life and death
Epigallocatechin gallate (EGCG) is a flavonoid belonging to the chemical class of falvan-3-
ols (catechins) esterified with gallic acid. It is the main catechin found in green tea (Camellia …
ols (catechins) esterified with gallic acid. It is the main catechin found in green tea (Camellia …
Molecular processes involved in B cell acute lymphoblastic leukaemia
C Malouf, K Ottersbach - Cellular and molecular life sciences, 2018 - Springer
B cell leukaemia is one of the most frequent malignancies in the paediatric population, but
also affects a significant proportion of adults in developed countries. The majority of infant …
also affects a significant proportion of adults in developed countries. The majority of infant …
Aberrant signaling pathways in T-cell acute lymphoblastic leukemia
D Bongiovanni, V Saccomani, E Piovan - International journal of …, 2017 - mdpi.com
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the
malignant transformation of immature progenitors primed towards T-cell development …
malignant transformation of immature progenitors primed towards T-cell development …